1. Association between troponin level and medium term mortality in 20,000 hospital patients
- Author
-
Hinton, Jonathan, Mariathas, Mark, Gabara, Lavinia, Allan, Rick, Nicholas, Zoe, Kwok, Chun Shing, Ramamoorthy, Sanjay, Calver, Alison, Corbett, Simon, Jabbour, Richard J., Mahmoudi, Michael, Rawlins, John, Sirohi, Rohit, Wilkinson, J., Cook, Paul, Martin, Glen P., Mamas, Mamas, and Curzen, Nicholas
- Abstract
Introduction: cardiac troponin (cTn) concentrations above the manufacturer recommended upper limit of normal (ULN) are frequently seen in hospital patients without a clinical presentation consistent with type 1 myocardial infarction, and the significance of this is uncertain. The aim of this study was to assess the relationship between medium term mortality and cTn concentration in a large consecutive hospital population, regardless of whether there was a clinical indication for performing the test.Method: this prospective observational study included 20,000 consecutive in-hospital and outpatient patients who had a blood test for any reason at a large teaching hospital, and in whom a hs-cTnI assay was measured, regardless of the original clinical indication. Mortality was obtained via NHS Digital. Results: A total of 20,000 patients were included in the analysis and 18,282 of these (91.4%) did not have a clinical indication for cTnI testing. Overall, 2825 (14.1%) patients died at a median of 809 days. The mortality was significantly higher if the cTnI concentration was above the ULN (45.3% versus 12.3% pConclusion: in a large, unselected hospital population, in 91.4% of whom there was no clinical indication for testing, cTnI concentration was independently associated with medium term cardiovascular and non-cardiovascular mortality in the statistical model tested.
- Published
- 2023